These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 326454

  • 1. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC, Hockley M, Fenton SS, Wilson DR.
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [Abstract] [Full Text] [Related]

  • 2. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E, Flores-Izquierdo G, Ortiz F, Pizzuto J, Cruz M, Gutiérrez ML.
    Arch Invest Med (Mex); 1978 Jun; 9(3):503-10. PubMed ID: 361009
    [Abstract] [Full Text] [Related]

  • 3. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
    Anderton JL, Fananapazir L, Eccleston M.
    Proc Eur Dial Transplant Assoc; 1977 Jun; 14():342-50. PubMed ID: 341136
    [Abstract] [Full Text] [Related]

  • 4. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 5. A simple test for early detection of severe renal homograft rejection.
    Oppolzer R, Leithner C, Wolf A, Pinggera W, Stummvoll H.
    Proc Eur Dial Transplant Assoc; 1975 Jun; 11():326-32. PubMed ID: 667
    [Abstract] [Full Text] [Related]

  • 6. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E, Seyfarth M, Templin R, Schneider P, Klinkmann H.
    Proc Eur Dial Transplant Assoc; 1978 Jun; 15():466-72. PubMed ID: 368788
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of NAG and FDP in acute renal graft rejection.
    Garcia B, Thompson AE, Tucker SM, Wing AJ.
    Proc Eur Dial Transplant Assoc; 1975 Jun; 11():311-9. PubMed ID: 1105552
    [Abstract] [Full Text] [Related]

  • 8. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M, Oetliker O, Montandon A, Beck EA.
    Schweiz Med Wochenschr; 1975 Aug 16; 105(33):1040-7. PubMed ID: 1099647
    [Abstract] [Full Text] [Related]

  • 9. Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejection.
    Gonick HC, Stiehm ER, Saldanha LF.
    Curr Probl Clin Biochem; 1979 Aug 16; (9):257-72. PubMed ID: 376226
    [Abstract] [Full Text] [Related]

  • 10. [Fibrin fibrinogen degradation products in the urine of patients with kidney transplantations].
    Leithner C, Oppolzer R, Wolf A, Pinggera W, Stummvoll HK.
    Wien Med Wochenschr; 1975 Oct 10; 125(41):598-9. PubMed ID: 775807
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E, Seyfarth M, Templin R, Schneider P, Klinkmann H.
    Z Urol Nephrol; 1978 Nov 10; 71(11):787-97. PubMed ID: 366978
    [Abstract] [Full Text] [Related]

  • 12. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, van Damme B, Vermylen J.
    Clin Nephrol; 1976 Mar 10; 5(3):105-13. PubMed ID: 1261101
    [Abstract] [Full Text] [Related]

  • 13. [Fibrin degradation products (FDP) in the urine after kidney transplantation].
    Malý J, Pecka M, Erben J, Radochová D, Bláha M, Vanásek J, Siroký O, Zahradník J.
    Vnitr Lek; 1983 Jul 10; 29(6):598-603. PubMed ID: 6351421
    [No Abstract] [Full Text] [Related]

  • 14. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
    Kunikata S, Ikegami M, Imanishi M, Nishioka T, Ishii T, Uemura T, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1989 Aug 10; 35(8):1299-304. PubMed ID: 2816597
    [Abstract] [Full Text] [Related]

  • 15. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M, Bergentz SE, Hedner U, Nilsson IM.
    Scand J Urol Nephrol; 1976 Aug 10; 10(1):56-62. PubMed ID: 775625
    [Abstract] [Full Text] [Related]

  • 16. Urine plasmin-like substances as an index of kidney allograft rejections.
    Fukao K, Kashiwagi N, Kajiwara T, Ishikawa M, Husberg B, Weil R, Starzl TE.
    Transplantation; 1977 May 10; 23(5):407-13. PubMed ID: 141117
    [Abstract] [Full Text] [Related]

  • 17. [Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants].
    André E, Kessler M, Briquel ME, Alexandre P, Hurault de Ligny B, Huriet C.
    Pathol Biol (Paris); 1983 Jan 10; 31(1):23-7. PubMed ID: 6343962
    [Abstract] [Full Text] [Related]

  • 18. [Practical value of the determination of urinary fibrin degradation products in the early management of renal transplants].
    André E, Kessler M, Briquel ME, Alexandre P, Hurault de Ligny B, Huriet C.
    Sem Hop; 1983 Jun 02; 59(22):1669-73. PubMed ID: 6308788
    [Abstract] [Full Text] [Related]

  • 19. Polyomavirus nephropathy after renal transplantation: a single centre experience.
    Kim HC, Hwang EA, Han SY, Park SB, Park KK.
    Nephrology (Carlton); 2005 Apr 02; 10(2):198-203. PubMed ID: 15877682
    [Abstract] [Full Text] [Related]

  • 20. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 02; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.